FindTrial
Sign In

Effect of interventional pain management in patients with chronic migraine without aura.

Effect of interventional pain management on Calcitonin Gene-Related Peptide as a therapeutic biomarker in patients with chronic migraine without aura. - Interventional pain management

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018789
Enrollment
60
Registered
2019-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura

Interventions

Intervention1: Interventional pain management: Following are the interventional blocks performed 1.USG guided Greater occipital nerve block 2.USG guided Supraorbital nerve block 3.Intranasal Sphenopa

Sponsors

Dr Ashok kumar BK
Lead Sponsor
Dr Savitha K S MD PhD
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Both Sex Body Mass Index 25to30 Age 18to45 years Patients with chronic migraine without aura

Exclusion criteria

Exclusion criteria: Pregnant Woman Breastfeeding mother Alcoholics Tobacco users Patent with a psychiatric disorder Patients with uncontrolled hypertension and Diabetes mellitus. Allergy to Study drug Patients with neurological disorders Infection at the procedure site

Design outcomes

Primary

MeasureTime frame
CGRP levelsTimepoint: 2 and 4 weeks—

Secondary

MeasureTime frame
Frequency, intensity and duration of migraineTimepoint: 2 and 4 weeks—

Countries

India

Contacts

Public ContactDr Savitha K S MD PhD

Kempegowda Institute of medical sciences and research center

drashokkumarbk@yahoo.co.in9986071780

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026